Promoter methylation and expression changes of BRCA1 in cancerous tissues of patients with sporadic breast cancer

Li,Qiuyun; Wei,Wei; Jiang,Yi; Yang,Huawei; Liu,Jianlun

doi:10.3892/ol.2015.2908

Promoter methylation and expression changes of BRCA1 in cancerous tissues of patients with sporadic breast cancer

Authors:
- Qiuyun Li
- Wei Wei
- Yi Jiang
- Huawei Yang
- Jianlun Liu
View Affiliations

Affiliations: Department of Breast Surgery, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China
Published online on: January 27, 2015 https://doi.org/10.3892/ol.2015.2908
Pages: 1807-1813

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

BRCA1 is a susceptibility gene that has a genetic predisposition for breast cancer. BRCA1 gene mutation is closely associated with familial hereditary breast cancer, but the BRCA1 gene mutation is rarely found in sporadic breast cancer. According to previous studies, decreased expression of BRCA1 was detected in certain types of sporadic breast cancer. Aberrant methylation of DNA promoter CpG islands is one of the mechanisms by which tumor suppressor gene expression and function is lost. The aim of the present study was to investigate BRCA1 gene expression, methylation status and clinical significance in sporadic types of breast cancer. Quantitative polymerase chain reaction (PCR) and bisulfite sequencing PCR were respectively used to detect expression differences of BRCA1 mRNA and BRCA1 methylation in the 49 cancerous and paired non‑cancerous samples from patients with breast cancer. The associations of BRCA1 expression and methylation status with the clinicopathologic characteristics were analysed. BRCA1 mRNA expression levels in the 49 breast cancer tissues were lower than those in the paired non‑cancerous tissues. There was a significant statistical difference (P=0.001). BRCA1 mRNA expression was not associated with the main clinicopathologic characteristics. Frequency of the BRCA1 promoter methylation in the breast cancerous tissues was significantly higher than that in the non‑cancerous tissues (P=0.007); BRCA1 gene methylation status was negatively correlated with mRNA expression (P=0.029); and BRCA1 methylation exhibited no association with all clinicopathological features. DNA promoter hypermethylation may be the potential mechanism accounting for BRCA1 expression silence in part of sporadic types of breast cancer. Some patients with hypermethylated BRCA1 may display favorable clinicopathological status.

View Figures

View References

1	Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 250:1684–1689. 1990. View Article : Google Scholar : PubMed/NCBI
2	Deng CX and Wang RH: Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum Mol Genet. 12(Spec No 1): R113–R123. 2003. View Article : Google Scholar : PubMed/NCBI
3	Xu B, St K and Kastan MB: Involvement of BRCA1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol. 21:3445–3450. 2001. View Article : Google Scholar : PubMed/NCBI
4	Ralhan R, Kaur J, Kreienberg R and Wiesmüller L: Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett. 248:1–17. 2007. View Article : Google Scholar
5	Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:66–71. 1994. View Article : Google Scholar : PubMed/NCBI
6	Easton DF, Bishop DT, Ford D and Crockford GP: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 52:678–701. 1993.PubMed/NCBI
7	Narod SA, Ford D, Devilee P, et al: An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet. 56:254–264. 1995.PubMed/NCBI
8	Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 62:676–689. 1998. View Article : Google Scholar : PubMed/NCBI
9	Hedenfalk I, Ringner M, Ben-Dor A, et al: Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci USA. 100:2532–2537. 2003. View Article : Google Scholar : PubMed/NCBI
10	Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet. 9:444–450. 1995. View Article : Google Scholar : PubMed/NCBI
11	Magdinier F, Ribieras S, Lenoir GM, Frappart L and Dante R: Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene. 17:3169–3176. 1998. View Article : Google Scholar
12	Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE and Dobrovic A: Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis. 21:147–151. 2000. View Article : Google Scholar : PubMed/NCBI
13	Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet. 3:415–428. 2002.PubMed/NCBI
14	Franco R, Schoneveld O, Georgakilas AG and Panayiotidis MI: Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 266:6–11. 2008. View Article : Google Scholar : PubMed/NCBI
15	Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
16	Das PM and Singal R: DNA methylation and cancer. J Clin Oncol. 22:4632–4642. 2004. View Article : Google Scholar : PubMed/NCBI
17	Feinberg AP and Vogelstein B: Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 301:89–92. 1983. View Article : Google Scholar : PubMed/NCBI
18	Choi JY, James SR, Link PA, et al: Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis. 30:1889–1897. 2009. View Article : Google Scholar : PubMed/NCBI
19	Robertson KD: DNA methylation and chromatin-unraveling the tangled web. Oncogene. 21:5361–5379. 2002. View Article : Google Scholar : PubMed/NCBI
20	Baylin SB and Ohm JE: Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction. Nat Rev Cancer. 6:107–116. 2006. View Article : Google Scholar : PubMed/NCBI
21	Esteller M, Silva JM, Dominguez G, et al: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 92:564–569. 2000. View Article : Google Scholar : PubMed/NCBI
22	Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG and Eyfjord JE: Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res. 8:R382006. View Article : Google Scholar : PubMed/NCBI
23	Rice JC, Massey-Brown KS and Futscher BW: Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene. 17:1807–1812. 1998. View Article : Google Scholar : PubMed/NCBI
24	Catteau A, Harris WH, Xu CF and Solomon E: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 18:1957–1965. 1999. View Article : Google Scholar : PubMed/NCBI
25	Turner N, Tutt A and Ashworth A: Hallmarks of ‘BRCAness’ in sporadic cancers. Nat Rev Cancer. 4:814–819. 2004. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
27	Chu D, Zhang Z, Li Y, et al: Prediction of colorectal cancer relapse and prognosis by tissue mRNA levels of NDRG2. Mol Cancer Ther. 10:47–56. 2011. View Article : Google Scholar : PubMed/NCBI
28	Zhang J and Powell SN: The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res. 3:531–539. 2005. View Article : Google Scholar : PubMed/NCBI
29	Ting NS and Lee WH: The DNA double-strand break response pathway: becoming more BRCAish than ever. DNA Repair (Amst). 3:935–944. 2004. View Article : Google Scholar
30	De Vargas Roditi L and Michor F: Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis. J Theor Biol. 273:207–215. 2011. View Article : Google Scholar : PubMed/NCBI
31	Valentin MD, da Silva SD, Privat M, Alaoui-Jamali M and Bignon YJ: Molecular insights on basal-like breast cancer. Breast Cancer Res Treat. 134:21–30. 2012. View Article : Google Scholar : PubMed/NCBI
32	Warmoes M, Jaspers JE, Pham TV, et al: Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer. Mol Cell Proteomics. 11:M111.0133342012. View Article : Google Scholar : PubMed/NCBI
33	Esteller M, Silva JM, Dominguez G, et al: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 92:564–569. 2000. View Article : Google Scholar : PubMed/NCBI
34	Rice JC, Ozcelik H, Maxeiner P, Andrulis I and Futscher BW: Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis. 21:1761–1765. 2000. View Article : Google Scholar : PubMed/NCBI
35	Krasteva ME, Bozhanov SS, Antov GG, Gospodinova ZI and Angelov SG: Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status. Neoplasma. 59:85–91. 2012. View Article : Google Scholar
36	Xu X, Gammon MD, Zhang Y, et al: BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat. 115:397–404. 2009. View Article : Google Scholar :
37	Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD and Richardson AL: BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat. 91:179–186. 2005. View Article : Google Scholar : PubMed/NCBI
38	Li S, Rong M and Iacopetta B: DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett. 237:272–280. 2006. View Article : Google Scholar
39	Krasteva ME, Bozhanov SS, Antov GG, Gospodinova ZI and Angelov SG: Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status. Neoplasma. 59:85–91. 2012. View Article : Google Scholar